Fu-Shan Xue | Clinical Medicine | Outstanding Scientist Award

Posted on by Pencis

Prof. Fu-Shan Xue | Clinical Medicine | Outstanding Scientist Award

Fuzhou University Affiliated Provincial Hospital | China

Author Profile

Scopus

Orcid ID

🎓 THE REMARKABLE JOURNEY OF FU-SHAN XUE: A TRAILBLAZER IN ANESTHESIOLOGY

🎓 EARLY ACADEMIC PURSUITS

Fu-Shan Xue’s academic journey laid a strong foundation for his outstanding future career. His deep passion for medical sciences, particularly anesthesiology and surgery, led him to pursue rigorous academic training, culminating in his appointment as a Doctoral Supervisor. His dedication during his formative academic years built the groundwork for his later roles as a Chief Physician and Distinguished Professor at Beijing Anzhen Hospital, Capital Medical University.

🏥 PROFESSIONAL ENDEAVORS

Dr. Xue’s professional career is marked by exceptional achievements and prestigious appointments. Serving as the Chief Physician and Professor at the Anesthesiology and Surgery Center of Beijing Anzhen Hospital, he became one of the leading figures in the field. Beyond his hospital responsibilities, he has been recognized as:

  • National Candidate of the "New Century Millions of Talents Project",

  • Expert with Special Allowance of the State Council,

  • Young and Middle-Aged Expert with Outstanding National Contributions,

  • Leading Talent of the National "Ten-Thousand Talents Program".

These distinctions reflect his national and international stature as a pioneering anesthesiologist.

📚 CONTRIBUTIONS AND RESEARCH FOCUS ON CLINICAL MEDICINE

Dr. Xue has significantly advanced the field of anesthesiology through his extensive research and innovation. His focus spans various critical areas, including:

  • Innovative techniques in anesthesia and perioperative medicine,

  • Enhancing patient safety during surgical procedures,

  • Developing new surgical and anesthetic methodologies.

His contributions have led to real-world advancements in clinical practices, making surgeries safer and improving patient outcomes.

🌍 IMPACT AND INFLUENCE

The impact of Dr. Xue’s work extends far beyond the walls of his institution:

  • Published more than 1,180 academic papers, including over 830 as the first and corresponding author in SCI-indexed journals,

  • Edited and translated 15 professional books that serve as key references in the field,

  • Achieved 86 national patents (including 11 invention patents) and 10 foreign patents,

  • Honored with 8 prestigious awards at the provincial and ministerial levels.

Dr. Xue’s influence resonates through medical education, research innovation, and clinical excellence in China and globally.

📈 ACADEMIC CITATIONS

Given his prolific research output, Dr. Xue’s work has been widely cited across national and international medical communities. His extensive citation record demonstrates the foundational importance of his research in advancing anesthesiology and surgery disciplines. He stands as a major reference point for upcoming anesthesiologists and researchers worldwide.

🏆 LEGACY AND FUTURE CONTRIBUTIONS

Fu-Shan Xue’s legacy is already deeply entrenched in the history of anesthesiology:

  • A pioneer in bridging clinical practice and innovative research,

  • A mentor to new generations of physicians and researchers,

  • An architect of safer and more effective anesthesia practices.

Looking ahead, Dr. Xue continues to drive cutting-edge innovations, pursue international collaborations, and mentor young talents. His future contributions are expected to further revolutionize perioperative medicine, enhance global surgical standards, and inspire countless young professionals to follow in his footsteps.

🏅 AWARDS AND HONORS

  • China Distinguished Research Award of Anaesthesia

  • China Distinguishable Anaesthetist Award

  • Wu Yang Medical Medicine Award

  • Nie Jiedong Medical Award

  • Health Defender of Healthy China

  • Top 10 Innovative Medical Experts

These accolades underscore his unparalleled contributions to the advancement of medical science and patient care.

📑NOTABLE PUBLICATIONS

"The UCP2/PINK1/LC3b-mediated mitophagy is involved in the protection of NRG1 against myocardial ischemia/reperfusion injury" 

  • Authors: X., Li, Xintao , X., Li, Xinyue , T., Tian, Tian , M., Jin, Mu , F., Xue, Fushan
  • Journal: Redox Biology
  • Year: 2025

"Esketamine at a Clinical Dose Attenuates Cerebral Ischemia/Reperfusion Injury by Inhibiting AKT Signaling Pathway to Facilitate Microglia M2 Polarization and Autophagy" 

  • Authors: Y., Gao, Ying , L., Li, Lu , F., Zhao, Fang , M., Jin, Mu , F., Xue, Fushan
  • Journal: Drug Design, Development and Therapy
  • Year: 2025

"Subglottic airway injury during fiberscope-monitored intubation with a supraglottic airway device: A randomized controlled comparison of three tracheal tubes" 

  • Authors: K., Su, Kai , S., Xu, Shangjun , H., Wang, Haixia , F., Xue, Fushan , M., Tian
  • Journal: Ming Chinese Medical Journal
  • Year: 2025

Pinelopi Petropoulou | Diabetes | Best Researcher Award

Posted on by Pencis

Dr. Pinelopi Petropoulou | Diabetes | Best Researcher Award

University of West Attica | Greece

Author Profile

Scopus

Orcid ID

📚 DR. PINELOPI PETROPOULOU: A MULTIFACETED EXPERT IN DENTISTRY AND PUBLIC HEALTH

📖 EARLY ACADEMIC PURSUITS

Dr. Pinelopi Petropoulou was born and resides in Athens, Greece. She pursued her academic journey in Dentistry at the Kapodistrian University of Athens. Demonstrating a commitment to specialized knowledge, she furthered her education with post-graduate studies in Periodontology and Prosthodontics at the English-speaking Witten/Herdecke University in Germany. Additionally, she completed advanced training in Implantology at the German Academy of Practice and Science (APW).

Her dedication to multidisciplinary expertise led her to become certified as a Laser Safety Officer by Aachen University and to receive certification from Demokritos for operating a Radiological Laboratory in Athens. Moreover, she is currently a Ph.D. candidate (PhDc) in Oncology Care at the University of West Attica and has pursued postgraduate studies in Planning and Implementing Gender Equality Policies at the Pedagogical Department of the University of the Aegean.

💼 PROFESSIONAL ENDEAVORS

Dr. Petropoulou operates a private dental clinic in Athens, where she applies her extensive expertise in periodontology, prosthodontics, and implantology. Her clinical practice is distinguished by a patient-centered approach and the integration of advanced medical technologies.

In addition to her clinical work, Dr. Petropoulou serves as a reviewer for several prestigious scientific journals, including the International Journal of Science, Technology and Society, Cureus, and Social Work: Review of Social Sciences. Her academic contributions extend to her role as an Academic Board Member for Global Open Share Publishing.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON DIABETES

Dr. Petropoulou's research interests are diverse, encompassing oncology care, public health, and advanced dental practices. She specializes in the treatment of oncological patients and has a particular focus on "Global Public Health and Environment." Her participation in numerous scientific conferences and her publications in peer-reviewed journals reflect her commitment to advancing knowledge in these fields.

Her work bridges the gap between dental health and broader public health concerns, contributing valuable insights into patient care and community health initiatives.

🌍 IMPACT AND INFLUENCE

Dr. Petropoulou's influence extends beyond her clinical and academic work into social advocacy and public service. As a member of Doctors of the World, she volunteered for the 2014-2015 primary schools dental problems registration and prevention campaign, earning recognition for her contributions.

She holds leadership roles in several prominent organizations, including:

  • Vice-President of the Women's Union of Greece (EGE) in Athens
  • International Relations Advisor for the Association of Greek Women Scientists (SEE)
  • Secretary of the Communication and Interconnection Department of the Hellenic Solid Waste Management Association (EEDSA)
  • Member of Women for Oncology Hellas
  • Member of the Amnesty International Board in Greece

Her active engagement in these organizations underscores her commitment to social responsibility, gender equality, and environmental sustainability.

📊 ACADEMIC CITATIONS

Dr. Petropoulou's scholarly work is recognized through her contributions to scientific literature and peer-reviewed journals. Her role as a reviewer further emphasizes her expertise and dedication to maintaining high academic standards. Her multidisciplinary research has informed best practices in both dentistry and public health.

🏆 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Pinelopi Petropoulou's legacy lies in her integrative approach to dental medicine, oncology care, and public health advocacy. Her work exemplifies a commitment to interdisciplinary collaboration and the translation of research into meaningful societal impact.

Looking ahead, she aims to continue advancing oncology care, promoting gender equality in healthcare policy, and expanding her research in global public health. Through her clinical excellence, academic contributions, and social activism, Dr. Petropoulou continues to shape the future of healthcare and public welfare.

🌟 OTHER NOTABLE ACHIEVEMENTS

  • Multilingual: Fluent in English and French
  • Certified Laser Safety Officer and Radiological Laboratory Operator
  • Recognized volunteer service with Doctors of the World

Dr. Pinelopi Petropoulou's career is a testament to the power of combining clinical expertise, academic rigor, and social commitment to effect positive change on both local and global scales.

NOTABLE PUBLICATIONS📑

"Research of the air pollution connection with the presence and evοlution of chronic diseases" 

  • Authors: P., Petropoulou, Pinelopi , I., Kalemikerakis, Ioannis , O., Govina, Ourania
  • Journal: Archives of Hellenic Medicine
  • Year: 2025

Jaina Razbek | Epidemiology | Best Scholar Award

Posted on by Pencis

Dr. Jaina Razbek | Epidemiology | Best Scholar Award

Xinjiang Medical University | China

Author Profile

Scopus

Orcid ID

Jaina Razbek, Ph.D. Candidate 🩺📊

Pioneering Research in Tuberculosis Prevention and Genetic Epidemiology

EARLY ACADEMIC PURSUITS 🎓

Jaina Razbek embarked on her academic journey with a strong foundation in public health and epidemiology. She is currently pursuing her doctoral studies at the Department of Epidemiology and Health Statistics, College of Public Health, Xinjiang Medical University. Her early academic training provided her with the skills to analyze disease patterns, conduct large-scale epidemiological studies, and develop statistical models for public health interventions.

PROFESSIONAL ENDEAVORS & RESEARCH PROJECTS 🔬📚

Jaina's research primarily focuses on tuberculosis prevention and control, genetic epidemiology, and health economic evaluations. She has actively contributed to various prestigious research projects, playing critical roles in data organization, statistical analysis, and causal inference modeling.

Notable Research Projects:

🔹 Health Economic Evaluation of Early Screening and Preventive Treatment for Latent Tuberculosis Infection (2023-2025): Investigating cost-effectiveness models for TB prevention strategies.
🔹 Evaluation of Tuberculosis Prevention Models in Southern Xinjiang (2023-2024): Analyzing key intervention factors using cohort and implementation science frameworks.
🔹 Causal Effect Evaluation of the ‘Xinjiang Model’ for TB Prevention (2025-2028): Studying the impact of TB control policies through RE-AIM and stepped-cluster randomized trials.
🔹 Role of Vitamin D in Latent Tuberculosis Infection (2021-2024): Conducting causal inference studies on the effects of vitamin D in TB progression.

CONTRIBUTIONS & RESEARCH FOCUS ON EPIDEMIOLOGY🔍📖

Jaina’s research has significantly contributed to understanding the genetic and epidemiological factors influencing tuberculosis and metabolic diseases. Her studies focus on:

✅ Tuberculosis Prevention & Control – Developing early screening methods and evaluating intervention effectiveness.
✅ Genetic Polymorphisms & Disease Susceptibility – Examining the role of vitamin D receptor gene polymorphisms in TB.
✅ Public Health Strategies – Enhancing disease prevention strategies through statistical modeling and health economics.
✅ Epidemiological Methods & Causal Inference – Applying advanced statistical frameworks to investigate complex disease mechanisms.

IMPACT & INFLUENCE 🌍

Jaina's research has played a vital role in shaping tuberculosis prevention strategies in high-incidence regions like Xinjiang. Her contributions to causal inference in genetic epidemiology have furthered the understanding of gene-disease interactions, helping predict disease susceptibility and treatment responses.

Her involvement in major national and provincial-level research projects underscores her ability to bridge theoretical epidemiology with practical public health solutions.

ACADEMIC CITATIONS & SCHOLARLY OUTPUT 📑

Jaina Razbek has published multiple high-impact research papers in SCI-indexed journals, demonstrating her scholarly excellence. Some of her most notable publications include:

📄 Vitamin D Receptor Gene Polymorphisms Differentiated Between Tuberculosis Disease and Infection – Published in Infection and Drug Resistance (2024).
📄 Association of Serum Levels of TNF-α, IL-10, IFN-γ, and CXCL5 with Latent Tuberculosis – Published in Infection and Drug Resistance (2024).
📄 Causal Association Study of Metabolic Syndrome Development Using Longitudinal Data – Published in Scientific Reports (2024).
📄 Dynamic Progression and Risk Assessment of Metabolic Syndrome Using a Multi-State Markov Model – Published in Diabetes, Metabolic Syndrome, and Obesity (2022).
📄 Xinjiang Metabolic Syndrome Risk Prediction Model Using Interpretable Models – Published in BMC Public Health (2022).

These contributions have earned her widespread recognition, with citations in public health and epidemiology research worldwide.

LEGACY & FUTURE CONTRIBUTIONS 🔮

Jaina Razbek's research has laid the groundwork for improving tuberculosis prevention strategies through genetic and economic evaluations. Moving forward, she aims to:

🌟 Advance the field of epidemiological modeling for infectious diseases.
🌟 Develop precision medicine approaches for tuberculosis based on genetic susceptibility markers.
🌟 Integrate AI-driven analytics into public health decision-making.
🌟 Mentor future epidemiologists and expand global collaborations in disease prevention research.

CONCLUSION 🏆

Jaina Razbek is an emerging leader in epidemiology and public health research, with a deep commitment to disease prevention and health policy optimization. Her innovative research, impactful publications, and dedication to public health continue to shape the future of tuberculosis control and epidemiological science.

NOTABLE PUBLICATIONS📑

"Causal association study of the dynamic development of the metabolic syndrome based on longitudinal data" 

  • Authors: Razbek, J. , Bao, L. , Zhang, Y. , Daken, M. , Cao, M.
  • Journal: Scientific Reports
  • Year: 2024

"Vitamin D Receptor Gene Polymorphisms Differentiated Between Tuberculosis Disease and Infection: Causal Association Study" 

  • Authors: Razbek, J. , Chen, Y. , Yang, J. , Aili, A. , Cao, M.
  • Journal: Infection and Drug Resistance
  • Year: 2024

"Association Studies of Serum Levels of TNF-α, IL-10, IFN-γ and CXCL 5 with Latent Tuberculosis Infection in Close Contacts" 

  • Authors: Razbek, J. , Daken, M. , Chen, Y. , Wang, X. , Cao, M.
  • Journal: Infection and Drug Resistance
  • Year: 2024

"Opening the black box: interpretable machine learning for predictor finding of metabolic syndrome" 

  • Authors: Zhang, Y. , Zhang, X. , Razbek, J. , Daken, M. , Cao, M
  • Journal:BMC Endocrine Disorders
  • Year: 2022

"Construction of Xinjiang metabolic syndrome risk prediction model based on interpretable models" 

  • Authors: Zhang, Y. , Razbek, J. , Li, D. , Zhang, X. , Cao, M.
  • Journal: BMC Public Health
  • Year: 2022

Yulia Desheva | Immunology | Best Researcher Award

Posted on by Pencis

Dr. Yulia Desheva | Immunology | Best Researcher Award

Institute of Experimental Medicine | Russia

Author Profile

Scopus 

Orcid ID

🌟 Biography of Yulia Desheva 🌟

EARLY ACADEMIC PURSUITS 🎓

Yulia Desheva demonstrated an exceptional aptitude for the sciences early in her academic journey, culminating in advanced degrees in virology and immunology. Her academic focus honed in on understanding the molecular mechanisms underlying viral infections, particularly influenza. This foundation provided her with the skills to innovate within vaccine development and immunization strategies. Her dedication to research began in St. Petersburg, Russia, where she laid the groundwork for her contributions to global virology.

PROFESSIONAL ENDEAVORS 💼

As a Senior Scientist at the Institute of Experimental Medicine and a professor at St. Petersburg State University, Yulia Desheva plays a pivotal role in advancing vaccine research. Her professional career spans leadership roles in virology, where she collaborates with global institutions like Academia Sinica in Taiwan. She is a valued member of the International Society for Influenza and Other Respiratory Virus Diseases (ISIRV) and contributes to scientific journals as a reviewer for Virology Journal, Journal of Infection and Public Health, and more.

CONTRIBUTIONS AND RESEARCH FOCUS ON IMMUNOLOGY🧪

Desheva’s groundbreaking work centers on vaccine development and viral-bacterial interactions. Her achievements include:

  • Development of live influenza vaccines tailored for high-risk individuals.
  • Creation and evaluation of mucosal vaccines addressing viral-bacterial infections and COVID-19.
  • Studying neuraminidase antibodies to advance immunization efficacy.
    Her innovative approach to developing vaccines for avian influenza viruses has positioned her as a leader in the field. Additionally, her research focuses on reducing bacterial complications arising from influenza infections through novel vaccine designs.

IMPACT AND INFLUENCE 🌍

Yulia Desheva's contributions extend beyond her laboratory to impact global public health. Her research has:

  • Enhanced vaccine accessibility for high-risk populations.
  • Influenced global strategies for managing pandemics and viral outbreaks.
  • Strengthened scientific collaboration across international borders.

Her role as a mentor has also nurtured the next generation of scientists, ensuring her legacy within virology and immunology.

ACADEMIC CITATIONS 📚

  • Books Published: 2
  • Peer-Reviewed Articles: 54 (published in SCI and Scopus-indexed journals)
  • Citation Index: 10

These metrics reflect her dedication to advancing scientific knowledge in virology and vaccine development.

LEGACY AND FUTURE CONTRIBUTIONS 🚀

With 20 patents to her name and numerous ongoing research projects, Yulia Desheva is poised to continue driving innovations in vaccine science. Her collaborative work with global institutions ensures her contributions will remain at the forefront of addressing emerging infectious diseases. She is committed to creating safer and more effective vaccines for future generations, cementing her legacy as a pioneer in immunology.

HIGHLIGHTS OF PROFESSIONAL ACHIEVEMENTS 🌟

  • Patents: 20
  • Completed/Ongoing Projects: 20
  • Editorial Roles: Reviewer for leading journals in virology and public health.
  • International Collaborations: Academia Sinica, Taiwan.

Desheva’s relentless pursuit of innovation and her interdisciplinary approach continue to inspire advancements in science and medicine.

NOTABLE PUBLICATIONS 📑

"Pilot Study Results on Antibodies to the S- and N-Proteins of SARS-CoV-2 in Paired Sera from COVID-19 Patients with Varying Severity" 

  • Authors: Desheva, Y. , Lerner, A. , Shvedova, T. , Leontieva, G. , Suvorov, A.
  • Journal: Antibodies
  • Year: 2023

"Establishment of a Pseudovirus Platform for Neuraminidase Inhibiting Antibody Analysis" 

  • Authors: Desheva, Y. , Petkova, N. , Losev, I. , Chao, Y.-C. , Tsai, C.-H.
  • Journal: International Journal of Molecular Sciences
  • Year: 2023

"Immune Response and Laboratory markers in the Spectrum of Severity of COVID-19" 

  • Authors: Desheva, Y.A. , Shvedova, T.N. , Kudar, P.А. , Petrachkova, D.S. , Lerner, A.A.
  • Journal: Medicine Academic Journal
  • Year: 2023

"Antigenic Characterization of Neuraminidase of Influenza A/H7N9 Viruses Isolated in Different Years" 

  • Authors: Desheva, Y. , Losev, I. , Petkova, N. , Tsai, C.-H. , Chao, Y.-C.
  • Journal: Pharmaceuticals
  • Year: 2022

"Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice" 

  • Authors: Desheva, Y. , Leontieva, G. , Kramskaya, T. , Kudar, P. , Suvorov, A.
  • Journal: Microorganisms
  • Year: 2022

William Hanna Kutteh | Chromosomal Abnormalities | Excellence in Research 

Posted on by Pencis

Prof Dr. William Hanna Kutteh | Chromosomal Abnormalities | Excellence in Research 

University of Tennessee HSC and Baptist Women's Hospital | Unites States

Author Profile

Scopus

Google Scholar

🌟 Biography of William Hanna Kutteh, MD, PhD, HCLD, CC 🌟

William Hanna Kutteh is a distinguished physician, scientist, and educator with an exceptional career in reproductive endocrinology, obstetrics, and gynecology. His contributions span across academic research, clinical excellence, and education, solidifying his legacy as a pioneer in reproductive health.

🏛️ EARLY ACADEMIC PURSUITS

William Hanna Kutteh embarked on his academic journey at Wake Forest University, earning a Bachelor of Arts in Biology with a minor in Chemistry (1971-1975). His keen interest in immunology led him to pursue graduate studies at Duke University, where he took advanced courses in immunology under the mentorship of Dr. Jeff Dawson (1975-1978).

He furthered his research with a Ph.D. in Molecular Cell Biology and Immunology from the University of Alabama at Birmingham (1978-1981), mentored by Dr. Jiri Mestecky. Following this, he achieved his MD at the Wake Forest University School of Medicine (1981-1985).

🩺 PROFESSIONAL ENDEAVORS

Key Positions

Dr. Kutteh has held prominent positions across leading institutions:

  • Founding Partner & Director at the Fertility Associates of Memphis
  • Professor of Obstetrics and Gynecology, University of Tennessee Health Sciences Center
  • Clinical Professor, Vanderbilt University Medical Center
  • Consulting Gynecologist, St. Jude Children’s Research Hospital, where he founded the Fertility Preservation Program

Special Roles

  • Director of Reproductive Endocrinology and Infertility at Baptist Memorial Hospital
  • Director of Resident Research Program, fostering the next generation of reproductive specialists
  • Director of EMIGS Simulation Training, advancing minimally invasive gynecologic surgery training

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CHROMOSOMAL ABNORMALITIES

Dr. Kutteh’s research encompasses:

  1. Reproductive Immunology: Exploring immunological causes of recurrent pregnancy loss.
  2. Fertility Preservation: Pioneering techniques for cancer patients.
  3. Endocrine Disorders: Advancing treatments in reproductive endocrinology and infertility.
  4. Minimally Invasive Surgery: Innovating gynecological surgical techniques.

His dedication to translational medicine bridges the gap between laboratory research and clinical application, improving patient outcomes.

🌍 IMPACT AND INFLUENCE

Dr. Kutteh has significantly impacted:

  • Patient Care: As a reproductive endocrinologist, he has transformed the lives of countless families.
  • Medical Education: Training residents and fellows in cutting-edge reproductive techniques.
  • Research: Leading groundbreaking studies funded by the NIH, such as a prestigious R01 grant from the National Institutes of Child Health and Human Development (1995-1999).

📚 ACADEMIC CITATIONS

Dr. Kutteh's scholarly contributions include:

  • Numerous peer-reviewed publications in high-impact journals.
  • Regular faculty roles at national and international conferences such as ASRM, ESHRE, and FASEB, where his expertise in early pregnancy and immunology is widely sought after.
  • Recognition by Newsweek and US News & World Report as one of the top reproductive endocrinologists in America.

🏅 HONORS AND AWARDS

Dr. Kutteh's accolades include:

  • America’s Top Doctors by Castle Connolly (1996-2022)
  • Top Reproductive Endocrinologist by US News & World Report (2012)
  • Louie C. Henry Faculty Award for excellence in clinical teaching (2024)

He has also received numerous Sigma Xi Research Awards and service awards from professional societies, such as the American Society for Reproductive Medicine (ASRM).

💡 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Kutteh’s legacy is marked by his dual commitment to advancing reproductive medicine and mentoring future leaders in the field. His ongoing work in fertility preservation, reproductive immunology, and minimally invasive surgery ensures his enduring influence.

As a visionary, he continues to push the boundaries of reproductive health through research, innovation, and education, shaping a brighter future for patients and practitioners alike.

📑NOTABLE PUBLICATIONS 

"Response: Would surgical retrieval of product of conception for the purpose of genetic analysis increase the risk of intra uterine adhesions?" 

  • Authors: Kutteh, W.H. , Maisenbacher, M. , Dahdouh, E.M.
  • Journal: Reproductive BioMedicine Online
  • Year: 2024

"Cell-Free DNA Analysis of Fetal Aneuploidies in Early Pregnancy Loss" 

  • Authors: Kutteh, W.H. , Miller, C.E. , Park, J.K. , Bhatt, S. , Keefe, D.L.
  • Journal: Journal of Clinical Medicine
  • Year: 2024

"Role of genetic analysis of products of conception and PGT in managing early pregnancy loss" 

  • Authors: Kutteh, W.H. , Papas, R.S. , Maisenbacher, M.K. , Dahdouh, E.M.
  • Journal: Reproductive BioMedicine Online
  • Year: 2024

"Expanding the role of chromosomal microarray analysis in the evaluation of recurrent pregnancy loss" 

  • Authors: Eliwa, J. , Papas, R.S. , Kutteh, W.H.
  • Journal: Journal of Reproductive Immunology
  • Year: 2024

"Is it time for new guidelines for recurrent pregnancy loss integrating genetic testing of products of conception and preimplantation genetic testing?" 

  • Authors: Kutteh, W.H. , Papas, R.S. , Dahdouh, E.M.
  • Journal: Fertility and Sterility
  • Year: 2024

Bin Zhang | Gene Mutation | Best Researcher Award

Posted on by Pencis

Prof Bin Zhang | Gene Mutation | Best Researcher Award

Jining Medical University | China

AUTHOR PROFILE

Scopus

Google Scholar

EARLY ACADEMIC PURSUITS

Bin Zhang's journey into the world of medical research began with a solid foundation in biomedical sciences. His early academic pursuits were marked by a dedication to understanding complex biological systems and a passion for contributing to the field of oncology. This academic dedication led him to become a young expert recognized under the prestigious Taishan Mount Scholars program in China.

PROFESSIONAL ENDEAVORS

In 2018, Bin Zhang was appointed as a researcher at the Affiliated Hospital of Jining Medical University. Here, he established the tumor metabolism research group, assuming the role of Principal Investigator. Under his leadership, the group has grown to focus on four key research directions: the regulatory mechanisms of tumor stem cells, the specificity of tumor biomacromolecules and energy metabolism, the regulation of energy metabolism by oncogenic gene mutations, and the screening of potential drugs targeting tumor metabolism.

CONTRIBUTIONS AND RESEARCH FOCUS ON GENE MUTATION

Bin Zhang's research has significantly advanced the understanding of tumor metabolism. His work has been published in esteemed journals such as Cell Reports Medicine, Biomaterials, Oncogene, Journal of Experimental & Clinical Cancer Research, and Stem Cells. These publications highlight his team's investigations into the intricate mechanisms of tumor biology and potential therapeutic targets. The research group delves into how tumor stem cells are regulated, how tumor biomacromolecules function, and how mutations in oncogenes affect energy metabolism, all of which are crucial for developing new cancer treatments.

IMPACT AND INFLUENCE

The impact of Bin Zhang's research is reflected in the high citation rate of his publications, with over 5000 citations to date and an H-Index of 34. His work has not only contributed valuable knowledge to the scientific community but has also influenced ongoing research and development in tumor metabolism. Furthermore, Bin Zhang has successfully secured ten patents, two of which have been transferred, demonstrating the practical applications and commercial potential of his research findings.

ACADEMIC CITES

Bin Zhang is also an active member of the academic community, serving as a reviewer for several high-impact journals including Stem Cells and Development, EBioMedicine, Stem Cell Research & Therapy, Molecular Carcinogenesis, and the Journal of Clinical Laboratory Medicine. His expertise is sought after in evaluating cutting-edge research and ensuring the quality of publications in these journals.

LEGACY AND FUTURE CONTRIBUTIONS

Bin Zhang's legacy in the field of tumor metabolism is marked by his innovative research and commitment to advancing cancer treatment. Currently, he is the principal investigator of two general projects funded by the National Natural Science Foundation of China, two projects funded by Shandong Province, and two projects funded by the Postdoctoral Foundation of China. His ongoing work promises to uncover new insights and develop novel therapies, continuing to push the boundaries of cancer research

NOTABLE PUBLICATIONS

A roadmap from research to clinical testing of mesenchymal stromal cell exosomes in the treatment of psoriasis 2023(7)

IL-13/IL-13RA2 signaling promotes colorectal cancer stem cell tumorigenesis by inducing ubiquitinated degradation of p53 2023(4)

Therapeutic Efficacy of Mesenchymal Stem/Stromal Cell Small Extracellular Vesicles in Alleviating Arthritic Progression by Restoring Macrophage Balance 2023(1)

Engineered EVs with pathogen proteins: promising vaccine alternatives to LNP-mRNA vaccines 2024

Arachidonic acid released by PIK3CA mutant tumor cells triggers malignant transformation of colonic epithelium by inducing chromatin remodeling 2024

Jinghan Song | Bioactive Materials and Genomic Research | Best Scholar Award

Posted on by Pencis

Ms. Jinghan Song | Bioactive Materials and Genomic Research | Best Scholar Award

The Fourth Military University  | China

Author Profile 

Scopus

EARLY ACADEMIC PURSUITS

Jinghan Song demonstrated exceptional academic prowess early on, laying a solid foundation during their undergraduate studies at Xi’an Jiaotong University. With a Bachelor of Science in Medicine, Jinghan excelled in major courses such as Bioinformatics, Physiology, Immunology, and Pathology, achieving an impressive average score of 90.1/100.

PROFESSIONAL ENDEAVORS

Building upon their undergraduate success, Jinghan pursued a Master of Science in Medicine at The Fourth Military Medical University. Throughout their academic journey, they delved into advanced topics including Advances in Cell Biology, Electron Microscopy, and Tissue Engineering and Regenerative Medicine. Their commitment to excellence is evident in their remarkable average score of 85.47/100.

CONTRIBUTIONS AND RESEARCH FOCUS ON BIOACTIVE MATERIALS AND GENOMIC RESEARCH

Jinghan has contributed significantly to the field of biomedical research, notably as a member of projects focusing on innovative materials and their applications. Noteworthy projects include the development of collagen materials cross-linked with DNA and the preparation method and application of polyphosphate modified collagen material. These endeavors underscore Jinghan's dedication to advancing biomedical science through innovative research.

IMPACT AND INFLUENCE

Jinghan's research has garnered attention within the academic community, as evidenced by their participation in prestigious academic conferences such as the 25th Academic Conference of Chinese Stomatological Association, where they presented posters and gave oral presentations. Their contributions have earned them recognition, including the First Prize for Poster at the aforementioned conference.

ACADEMIC CITATIONS

Jinghan's work has the potential for significant academic impact, as indicated by their involvement in patent projects and participation in academic conferences. Their research outputs may serve as valuable references for future studies in the fields of biomaterials and regenerative medicine.

LEGACY AND FUTURE CONTRIBUTIONS

As an outstanding graduate of Xi’an Jiaotong University and a recipient of multiple scholarships and awards, Jinghan is poised to make enduring contributions to the field of medicine and biomedical research. Their dedication to academic excellence and innovative research methodologies positions them as a promising scholar with the potential to shape the future of healthcare and biotechnology.

Notable Publications

Advances in materials-based therapeutic strategies against osteoporosis 2023(20)

Engineered extracellular vesicles: Regulating the crosstalk between the skeleton and immune system 2022(7)

Inflammation-associated ectopic mineralization 2023(1)